About Caligorrx
Caligorrx is a company based in Secaucus (United States) founded in 2002 was acquired by Diversis Capital in April 2016. Caligorrx has completed 1 acquisition, including The Coghlan Group. Caligorrx operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, August Research, ProductLife Group and Health Decisions, among others.
- Headquarter Secaucus, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Diversis Capital
(Apr 08, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Caligorrx
Detailed funding history for Caligorrx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Caligorrx
Caligorrx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Diversis Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in tech startups are made by Diversis Capital.
|
Locked | Locked | Locked |
Investor details for Caligorrx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caligorrx
Caligorrx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include The Coghlan Group.
Investment portfolio details for Caligorrx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical trial material management and randomization services are offered.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Caligorrx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Caligorrx
Detailed financials for Caligorrx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caligorrx Comparisons
Peer comparison for Caligorrx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caligorrx
Caligorrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, August Research, ProductLife Group and Health Decisions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
Clinical trial services are offered in Central and Eastern Europe.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Statistical consulting and data management for clinical trials are offered.
|
Detailed competitors of Caligorrx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caligorrx
Complete news archive for Caligorrx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caligorrx
Caligorrx was founded in 2002.
Caligorrx is headquartered in Secaucus, United States. It is registered at Secaucus, New Jersey, United States.
Founded in 2002 and based in Secaucus, United States, Caligorrx operates in the pharmaceutical and biotech sectors. Sourcing and supply chain solutions are provided for comparator drugs, rescue medications, combination therapies, and ancillary supplies. Logistical support is extended for worldwide clinical trials. Through Global Access Programs, regulatory solutions are facilitated to enable drug access for patients in regions lacking effective treatments or commercial availability.
Caligorrx's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.
Caligorrx has made 1 acquisition, including The Coghlan Group.
Caligorrx has 1 investor. Key investors include Diversis Capital.